Dementia is a group of diseases that involve having trouble with memory, thinking, reasoning and other brain functions. It is ...

The APOE gene is considered the strongest genetic risk factor for Alzheimer’s disease, with the APOE4 variant strongly linked to higher risk and the APOE2 variant associated with lower risk.

Voyager Therapeutics announces a new program targeting APOE4 in Alzheimer's patients, combining gene therapy and novel delivery methods.

- Voyager's wholly-owned Alzheimer's disease franchise now includes clinical-stage anti-tau antibody VY7523 as well as gene therapies targeting tau, amyloid, and APOE - ...

- Voyager’s wholly-owned Alzheimer’s disease franchise now includes clinical-stage anti-tau antibody VY7523 as well as gene therapies targeting tau, amyloid, and APOE - ...

- New program combines IV-delivered TRACER™ capsid with bifunctional payload to silence APOE in carriers of the high-risk APOE4 variant while delivering the protective APOE2 variant - - Voyager’s ...

The Department of Homeland Security is preparing to cut nearly 75% of staffing at the agency’s office tasked with developing and sharing threat intelligence with state and local partners ...

Outstanding Universal Value Outstanding Universal Value, or ‘OUV’ is described in Paragraph 49 of the Operational Guidelines as: ‘cultural and/or natural significance which is so exceptional as to ...

ALLSPRING SPECIAL MID CAP VALUE CIT E2- Performance charts including intraday, historical charts and prices and keydata.